TP53 and colorectal carcinoma: Similarly, comparing rs1042522 (TP53) and rs2279744 (MDM2) genotype combinations demonstrated that individuals with the wild type (GG) at TP53 and the mutant (TT) genotype at MDM2 had a significantly higher incidence of CRC development (P = 0.05) (Table 2).